Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals, Inc. | Chief Development Officer | $5.63M | -$1.04M | -15.7% | Jan 29, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|